Glenn Jay Jaffe
#132,033
Most Influential Person Now
Glenn Jay Jaffe's AcademicInfluence.com Rankings
Glenn Jay Jaffephilosophy Degrees
Philosophy
#6456
World Rank
#9492
Historical Rank
Ontology
#60
World Rank
#70
Historical Rank
Logic
#3618
World Rank
#4807
Historical Rank
Download Badge
Philosophy
Glenn Jay Jaffe's Degrees
- Doctorate Medicine University of Pennsylvania
Why Is Glenn Jay Jaffe Influential?
(Suggest an Edit or Addition)Glenn Jay Jaffe's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Ranibizumab and bevacizumab for neovascular age-related macular degeneration. (2011) (2428)
- Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. (2012) (1343)
- Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. (2000) (892)
- Intravitreal aflibercept for diabetic macular edema. (2014) (721)
- Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. (2014) (686)
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration: 2-Year Results: Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group‡* (2012) (626)
- Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. (2014) (505)
- Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials. (2016) (491)
- Optical coherence tomography to detect and manage retinal disease and glaucoma. (2004) (472)
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. (2019) (442)
- Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies. (2015) (436)
- Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. (2006) (414)
- Adalimumab in Patients with Active Noninfectious Uveitis. (2016) (402)
- Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. (2017) (394)
- cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. (1991) (333)
- Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial (2016) (332)
- Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies. (2016) (308)
- Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. (2019) (287)
- Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. (2008) (269)
- Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. (2013) (268)
- Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration (2011) (267)
- Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. (1995) (240)
- Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. (2013) (223)
- Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. (2000) (220)
- Risk of scar in the comparison of age-related macular degeneration treatments trials. (2014) (216)
- Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. (2001) (191)
- Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial (2017) (186)
- DIAGNOSIS OF VITREORETINAL ADHESIONS IN MACULAR DISEASE WITH OPTICAL COHERENCE TOMOGRAPHY (2000) (179)
- Reticular drusen associated with geographic atrophy in age-related macular degeneration. (2011) (177)
- Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial. (2017) (175)
- Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. (2014) (172)
- Uveitis in the southeastern United States. (1997) (170)
- Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. (2013) (165)
- Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. (2000) (155)
- Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration. (2011) (154)
- Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. (1999) (154)
- Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials. (2017) (150)
- Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. (2017) (146)
- C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial. (2020) (145)
- HAWK and HARRIER: 96-Week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration. (2020) (143)
- Methotrexate treatment for sarcoid-associated panuveitis. (1999) (143)
- Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. (2005) (143)
- Age-related changes of the normal visual field. (1986) (139)
- Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. (2003) (137)
- Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study). (2016) (135)
- Risk of inflammation, retinal vasculitis and retinal occlusion-related events with brolucizumab: post-hoc review of HAWK and HARRIER. (2020) (134)
- Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials. (2015) (134)
- Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT). (2014) (130)
- Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials. (2019) (129)
- Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. (2015) (128)
- Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III. (2018) (119)
- Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials. (2016) (117)
- Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. (2007) (116)
- Ocular manifestations of preeclampsia. (1987) (116)
- Evaluation of image artifact produced by optical coherence tomography of retinal pathology. (2004) (115)
- Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up. (2007) (113)
- Atypical, severe toxoplasmic retinochoroiditis in elderly patients. (1997) (111)
- Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. (2004) (111)
- Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy (2012) (104)
- Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. (2019) (103)
- Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial. (2017) (103)
- Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. (2010) (101)
- Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. (2018) (100)
- Oxidant-mediated Akt activation in human RPE cells. (2006) (99)
- Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial. (2019) (95)
- An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy. (1998) (94)
- Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. (1998) (94)
- Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes. (2009) (93)
- Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion (2003) (92)
- Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. (1995) (92)
- Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT). (2015) (88)
- Tissue plasminogen activator for postvitrectomy fibrin formation. (1990) (85)
- Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. (1999) (84)
- Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. (2003) (83)
- Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). (2016) (82)
- Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema. (2014) (81)
- Progression of nonproliferative diabetic retinopathy following cataract extraction. (1988) (80)
- Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials. (2014) (80)
- Expression and modulation of RPE cell membrane complement regulatory proteins. (2009) (77)
- Aryl hydrocarbon receptor deficiency causes dysregulated cellular matrix metabolism and age-related macular degeneration-like pathology (2013) (77)
- Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS. (2002) (77)
- Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. (1999) (76)
- Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy. (1996) (75)
- Combined phacoemulsification and pars plana vitrectomy. (1990) (74)
- Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor. (1999) (72)
- Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. (2005) (71)
- A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration. (2016) (70)
- VITRECTOMY FOR VITREOMACULAR TRACTION SYNDROME WITH MACULAR DETACHMENT (1995) (69)
- Evaluation of a delivery system providing long-term release of cyclosporine. (1996) (69)
- Diagnostic yield of vitrectomy in eyes with suspected posterior segment infection or malignancy. (2002) (67)
- Histopathologic features of adult-onset foveomacular pigment epithelial dystrophy. (1988) (66)
- Effect of an intravitreal cyclosporine implant on experimental uveitis in horses. (2000) (66)
- Fully automatic software for retinal thickness in eyes with diabetic macular edema from images acquired by cirrus and spectralis systems. (2013) (66)
- Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials. (2012) (65)
- Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. (2013) (64)
- Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator. (1989) (63)
- Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid. (2016) (62)
- New hypotheses on the pathogenesis and treatment of serous retinal detachment (1989) (61)
- Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS. (2002) (60)
- Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results. (2019) (59)
- SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY–DETERMINED MORPHOLOGIC PREDICTORS OF AGE-RELATED MACULAR DEGENERATION–ASSOCIATED GEOGRAPHIC ATROPHY PROGRESSION (2013) (58)
- Association of Disorganization of Retinal Inner Layers With Visual Acuity In Eyes With Uveitic Cystoid Macular Edema. (2017) (56)
- Differentiation of Diabetic Macular Edema From Pseudophakic Cystoid Macular Edema by Spectral-Domain Optical Coherence Tomography. (2015) (56)
- Topography of geographic atrophy in age-related macular degeneration. (2012) (56)
- EXUDATIVE RETINAL DETACHMENT AND RETINITIS ASSOCIATED WITH ACQUIRED SYPHILITIC UVEITIS (2000) (55)
- Expression of interleukin-1α, interleukin-1β, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells (1992) (55)
- Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. (2000) (55)
- Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. (1993) (54)
- The Impact of Macular Edema on Visual Function in Intermediate, Posterior, and Panuveitis (2012) (53)
- Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study. (2015) (52)
- Effect of INS37217, a P2Y(2) receptor agonist, on experimental retinal detachment and electroretinogram in adult rabbits. (2002) (52)
- Treatment and pathogenesis of traumatic chorioretinal rupture (sclopetaria). (1994) (51)
- An intravitreal device providing sustained release of cyclosporine and dexamethasone. (1994) (51)
- Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials. (2018) (49)
- Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials. (2015) (49)
- Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results. (2012) (48)
- IDENTIFICATION OF FLUID ON OPTICAL COHERENCE TOMOGRAPHY BY TREATING OPHTHALMOLOGISTS VERSUS A READING CENTER IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS (2015) (48)
- Filtering bleb thrombolysis with tissue plasminogen activator. (1988) (48)
- Caspase-8-mediated apoptosis in human RPE cells. (2007) (47)
- Demographic-related variations in posterior segment ocular sarcoidosis. (2004) (47)
- Deep longitudinal transfer learning-based automatic segmentation of photoreceptor ellipsoid zone defects on optical coherence tomography images of macular telangiectasia type 2 (2018) (47)
- SD-OCT and autofluorescence characteristics of autoimmune retinopathy (2011) (47)
- Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine A. (2000) (47)
- Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. (2008) (46)
- Intraocular lens changes after short- and long-term exposure to intraocular silicone oil. An in vivo study. (1998) (45)
- Wide field of view swept-source optical coherence tomography for peripheral retinal disease (2016) (45)
- Retinal phototoxicity from the operating microscope. The role of inspired oxygen. (1988) (45)
- Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies. (2017) (45)
- Ferromagnetic hyperthermia and iodine 125 brachytherapy in the treatment of choroidal melanoma in a rabbit model. (1989) (45)
- VITRECTOMY UPDATE FOR MACULAR TRACTION IN OCULAR TOXOCARIASIS (2000) (44)
- Antitransferrin receptor immunotoxin inhibits proliferating human retinal pigment epithelial cells. (1990) (43)
- Condensation on the posterior surface of silicone intraocular lenses during fluid-air exchange. (1995) (43)
- Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results. (2016) (43)
- Condensation on polymethylmethacrylate, acrylic polymer, and silicone intraocular lenses after fluid-air exchange in rabbits. (1996) (42)
- LIGHTNING MACULOPATHY: A Case Report (1994) (42)
- INCREASED INCIDENCE OF STERILE ENDOPHTHALMITIS AFTER INTRAVITREAL TRIAMCINOLONE ACETONIDE IN SPRING 2006 (2009) (42)
- Longitudinal analysis of reticular drusen associated with geographic atrophy in age-related macular degeneration. (2013) (42)
- Stability of recombinant tissue plasminogen activator. (1989) (42)
- Ab interno sclerostomy with a high-powered argon endolaser. (1988) (42)
- Retinal angiomatous proliferation. (2017) (41)
- Propionibacterium acnes endophthalmitis seven months after extracapsular cataract extraction and intraocular lens implantation. (1986) (41)
- Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation. (1990) (41)
- The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. (1999) (40)
- Baseline Predictors for Five-Year Visual Acuity Outcomes in the Comparison of AMD Treatment Trials. (2017) (40)
- Human RPE expression of cell survival factors. (2005) (40)
- Optical coherence tomography reader agreement in neovascular age-related macular degeneration. (2007) (40)
- Ca++-switch induction of RPE differentiation. (2006) (39)
- Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma. (2010) (38)
- Intravitreal clearance of tissue plasminogen activator in the rabbit. (1988) (38)
- Retinal nerve fiber layer thickness measurements: uveitis, a major confounding factor. (2015) (38)
- Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis. (2008) (37)
- Therapy for Ocular Toxoplasmosis (2011) (37)
- Modulation of macrophage colony stimulating factor in cultured human retinal pigment epithelial cells. (1992) (37)
- Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert Opinion. (2019) (36)
- Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis. (2008) (36)
- Petaloid Macular Edema and Outcomes in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) (2015) (36)
- Retinal thickening in iridocyclitis. (2008) (36)
- Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis. (2006) (35)
- Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells. (1997) (34)
- Effect of NF-κB inhibition on TNF-α-induced apoptosis in human RPE cells (2004) (34)
- Risk factors for postvitrectomy fibrin formation. (1990) (34)
- Assessment of Macular Microvasculature in Healthy Eyes of Infants and Children Using OCT Angiography. (2019) (34)
- Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results. (2020) (34)
- Expression of three forms of melanoma growth stimulating activity (MGSA)/gro in human retinal pigment epithelial cells. (1993) (34)
- Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress. (2014) (33)
- Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. (2014) (33)
- Magnetic resonance imaging of juxtapapillary plaques in cadaver eyes. (1990) (31)
- Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: CAM Report 5. (2020) (31)
- Retinopathy and Optic Neuropathy in Bone Marrow Transplantation for Breast Cancer (1996) (30)
- Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin. (2012) (30)
- Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. (2019) (30)
- Comparison of Visual Outcomes in Coats' Disease: A 20-Year Experience. (2017) (30)
- Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): fluorescein angiography and optical coherence tomography. (2013) (30)
- Activin expression by cultured human retinal pigment epithelial cells. (1994) (29)
- Retinal pigment epithelial cells of the posterior pole have fewer Na/K adenosine triphosphatase pumps than peripheral cells. (1991) (29)
- ASSOCIATION BETWEEN ANATOMICAL RESOLUTION AND FUNCTIONAL OUTCOMES IN THE MIVI-TRUST STUDIES USING OCRIPLASMIN TO TREAT SYMPTOMATIC VITREOMACULAR ADHESION/VITREOMACULAR TRACTION, INCLUDING WHEN ASSOCIATED WITH MACULAR HOLE (2015) (29)
- Assessment of retinal morphology with spectral and time domain OCT in the phase III trials of enzymatic vitreolysis. (2012) (27)
- Choroidal Findings in Eyes With Birdshot Chorioretinitis Using Enhanced-Depth Optical Coherence Tomography. (2016) (26)
- Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2 (2017) (26)
- Retinal phototoxicity from the operating microscope: a protective effect by the fovea. (1988) (26)
- Ab interno sclerostomy with a high-powered argon endolaser. Clinicopathologic correlation. (1989) (26)
- Beyond Performance Metrics: Automatic Deep Learning Retinal OCT Analysis Reproduces Clinical Trial Outcome. (2019) (26)
- New and emerging treatments for patients with uveitis. (2000) (25)
- Inhibition of proliferating lens epithelium with antitransferrin receptor immunotoxin (1994) (25)
- Reproducibility of Optovue RTVue Optical Coherence Tomography Retinal Thickness Measurements and Conversion to Equivalent Zeiss Stratus Metrics in Diabetic Macular Edema. (2015) (25)
- Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 12 optical coherence tomography and fluorescein angiography. (2013) (24)
- Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancer. (1991) (24)
- Reversible bull's-eye maculopathy associated with intravitreal fomivirsen therapy for cytomegalovirus retinitis. (2000) (24)
- Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis in human RPE cells. (2004) (23)
- A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned (2019) (23)
- The importance of Bcl-xL in the survival of human RPE cells. (2007) (22)
- Complement-Mediated Regulation of Apolipoprotein E in Cultured Human RPE Cells (2017) (21)
- Primary intraocular T-cell-rich large B-cell lymphoma. (2009) (21)
- Minoxidil inhibits ocular cell proliferation and lysyl hydroxylase activity. (1993) (21)
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results. (2020) (21)
- Expression of a chemokine by ciliary body epithelium in horses with naturally occurring recurrent uveitis and in cultured ciliary body epithelial cells. (2002) (21)
- Control of subretinal fluid: Experimental and clinical studies (1990) (21)
- Intravitreal A fl ibercept for Diabetic Macular Edema (2014) (20)
- MODIFIED EXTERNAL NEEDLE DRAINAGE PROCEDURE FOR RHEGMATOGENOUS RETINAL DETACHMENT (2003) (20)
- The Evolution of Fibrosis and Atrophy and Their Relationship with Visual Outcomes in Asian Persons with Neovascular Age-Related Macular Degeneration. (2019) (20)
- Paradoxical changes of retinal nerve fiber layer thickness in uveitic glaucoma. (2014) (19)
- A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema. (2016) (19)
- Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK (2021) (19)
- CYTOMEGALOVIRUS RETINITIS ASSOCIATED WITH HODGKIN'S DISEASE (1996) (19)
- REMOVAL OF OPTIC DISC STALKS DURING DIABETIC VITRECTOMY (1995) (18)
- Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials. (2019) (18)
- Development of IONIS-FB-LRx to Treat Geographic Atrophy Associated with AMD (2020) (18)
- Management of complications in eyes containing two intraocular lenses. (1998) (18)
- Fundus Autofluorescence Findings in Eyes With Birdshot Chorioretinitis. (2017) (17)
- MANAGEMENT OF EYES WITH BOTH IDIOPATHIC MACULAR HOLE AND CHOROIDAL NEOVASCULARIZATION (2001) (17)
- CORRELATION OF SUBRETINAL HYPERREFLECTIVE MATERIAL MORPHOLOGY AND VISUAL ACUITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. (2020) (17)
- Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II Trials (2018) (17)
- Tissue plasminogen activator for preserving inferior peripheral iridectomy patency in eyes with silicone oil. (1996) (17)
- Expression of interleukin-1 alpha, interleukin-1 beta, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. (1992) (16)
- The role of Bcl-xL in mouse RPE cell survival. (2011) (16)
- Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation with Other Measures of Disease Severity. (2020) (16)
- A centrifugal fluidic immunoassay for ocular diagnostics with an enzymatically hydrolyzed fluorogenic substrate. (2014) (16)
- Long-Term Safety and Efficacy of Adalimumab in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. (2020) (16)
- OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement (16)
- Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony. (2011) (15)
- Photoablation of ocular melanoma with a high-powered argon endolaser. (1989) (15)
- Five-Year Outcomes with Anti e Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials Comparison of Age-related Macular Degeneration Treatments Trials ( CATT ) Research Group (15)
- Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials. (2016) (15)
- Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT. (2019) (15)
- PHARMACOKINETICS OF THE GANCICLOVIR IMPLANT IN THE SILICONE-FILLED EYE (2001) (14)
- Spontaneous Closure of Full-Thickness Macular Hole With Epiretinal Membrane in Vitrectomized Eyes: Case Series and Review of Literature. (2017) (14)
- The effect of culture density and proliferation rate on the expression of ouabain-sensitive Na/K ATPase pumps in cultured human retinal pigment epithelium. (1991) (14)
- Retinal Drug Delivery (2006) (14)
- Diagnostic yield of vitreous biopsy in presumed sarcoidosis-related posterior segment inflammation (2012) (14)
- Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®) (2020) (13)
- Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials. (2016) (13)
- B-scan ultrasonography for the detection of macular thickening. (2003) (13)
- All-trans-retinal sensitizes human RPE cells to alternative complement pathway-induced cell death. (2013) (13)
- Quabain-sensitive Na+-K+ ATPase pumps in cultured human retinal pigment epithelium (1989) (13)
- Modulation of potassium transport in cultured retinal pigment epithelium and retinal glial cells by serum and epidermal growth factor. (1992) (12)
- Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software (2017) (12)
- Pharmacokinetics of the fluocinolone/5-fluorouracil codrug in the gas-filled eye. (2000) (12)
- Resveratrol Protects Against Hydroquinone-Induced Oxidative Threat in Retinal Pigment Epithelial Cells (2020) (12)
- Effect of Mutant IκB on Cytokine-Induced Activation of NF-κB in Cultured Human RPE Cells (2003) (12)
- Management of condensation on a foldable acrylic intraocular lens after vitrectomy and fluid-air exchange. (1997) (12)
- SAT0523 Adalimumab in Patients with Active, Non-Infectious Uveitis Requiring High-Dose Corticosteroids: the Visual-1 Trial (2015) (11)
- Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert® Implantation in Uveitic Eyes: A Retrospective Study (2015) (11)
- Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant (2020) (11)
- Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer. (1996) (11)
- Treatment of migraine headache after ocular surgery with intravenous metoclopramide hydrochloride. (1996) (11)
- Binding, coupling, and mRNA subtype heterogeneity of alpha 1-adrenergic receptors in cultured human RPE. (1995) (11)
- Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials. (2017) (10)
- Seven-year outcomes of uveitic macular edema: the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study results. (2020) (10)
- Retinal cavitations in macular telangiectasia type 2 (MacTel): longitudinal structure–function correlations (2020) (10)
- Ocular toxicity following high dose chemotherapy and autologous transplant. (1996) (10)
- Surgical Management in Patients With Uveitis (2007) (10)
- Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial. (2020) (9)
- PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial (2017) (9)
- PHARMACOKINETICS OF THE FLUOCINOLONE/5‐FLUOROURACIL CODRUG IN THE GAS‐FILLED EYE (2000) (9)
- Review: implants. (1994) (9)
- Risuteganib Protects against Hydroquinone–induced Injury in Human RPE Cells (2020) (9)
- SARILUMAB FOR RECALCITRANT CYSTOID MACULAR EDEMA IN NON-PARANEOPLASTIC AUTOIMMUNE RETINOPATHY. (2019) (9)
- Spontaneous dislocation of fluocinolone acetonide implant pellets from their suture struts. (2015) (9)
- Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular Degeneration. (2017) (8)
- RECONSTITUTION OF THE ELLIPSOID ZONE WITH TOCILIZUMAB IN AUTOIMMUNE RETINOPATHY. (2018) (8)
- Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery. (1992) (8)
- Sustained closure of surgically repaired macular holes after retinal detachment with submacular fluid. (1997) (8)
- MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants With nAMD and Persistent Retinal Fluid. (2022) (8)
- Predominantly Persistent Subretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). (2021) (8)
- Reproducibility of Optical Coherence Tomography Image Grading During the Comparisons of Age-Related Macular Degeneration Treatments Trials (CATT) (2012) (8)
- Transferrin-ricin A chain toxin limits the development of experimental proliferative vitreoretinopathy. (1996) (8)
- Inhibition of cultured human RPE cell proliferation and lysyl hydroxylase activity by hydroxy derivatives of minoxidil. (1994) (8)
- A Phase 2 Study of Encapsulated CNTF-Secreting Cell Implant (NT-501) in Patients With Geographic Atrophy Associated With Dry AMD-18 Month Results (2010) (7)
- Deep learning-based classification and segmentation of retinal cavitations on optical coherence tomography images of macular telangiectasia type 2 (2020) (7)
- Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema (2021) (7)
- Intraoperative fluorescein angioscopy in subretinal surgery. (1992) (7)
- The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy (2018) (7)
- Hypoxia precedes the development of experimental preretinal neovascularization (2004) (7)
- The Relationship of Vogt–Koyanagi–Harada Syndrome to Ocular Hypertension and Glaucoma (2017) (7)
- Recovery of Foveal Anatomy and Subfoveal Lucency after Pharmacologic and Surgical Macular Hole Closure in the Ocriplasmin Phase III Trials. (2017) (7)
- PERIVASCULAR THICKENING ON OPTICAL COHERENCE TOMOGRAPHY AS A MARKER OF INFLAMMATION IN BIRDSHOT RETINOCHOROIDITIS (2019) (7)
- Geographic atrophy risk factors in participants of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) (2013) (7)
- Spontaneous giant retinal pigment epithelial tear associated with panuveitis. (1997) (7)
- The relationship between pigment epithelial detachment and visual outcome in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy (2020) (6)
- Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy (iRORA) in Age-related Macular Degeneration: CAM Report 4 (2020) (6)
- The antiproliferative effect of a transferrin-toxin on human retinal pigment epithelial cells and rabbit fibroblasts. (1993) (6)
- COMPARISON OF SINGLE DRUSEN SIZE ON COLOR FUNDUS PHOTOGRAPHY AND SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY. (2021) (6)
- Reading Center Characterization of Central Retinal Vein Occlusion Using Optical Coherence Tomography During the COPERNICUS Trial. (2013) (6)
- POSTOPERATIVE FIBRIN FORMATION AND VISUAL OUTCOME AFTER PARS PLANA VITRECTOMY (1994) (6)
- Diagnostic vitrectomy in the management of ocular disease. (1993) (6)
- Monensin enhances the cytotoxic effect of antitransferrin receptor immunotoxin on cultured RPE cells. (1993) (6)
- Inhibition of Human Corneal Epithelium with Immunotoxin 454A12-rRA (1992) (6)
- Optical Coherence Tomography Signs of Early Atrophy in Age-related Macular Degeneration: Inter-Reader Agreement. CAM Report 6. (2021) (6)
- Role of Disorganization of Retinal Inner Layers as an Optical Coherence Tomography Biomarker in Diabetic and Uveitic Macular Edema. (2017) (6)
- Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical Trial. (2020) (5)
- Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting (2016) (5)
- In Vivo Analyses of the Developmental and Cell-specific Activity of the Human Retinal Guanylyl Cyclase-1 (GC1) Promoter (2003) (5)
- Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema (2021) (5)
- Effect of mutant IkappaB on cytokine-induced activation of NF-kappaB in cultured human RPE cells. (2003) (4)
- Current role of optical coherence tomography angiography: Expert panel discussion (2018) (4)
- Clinical-Pathological Correlation of Vogt-Koyanagi-Harada Disease. (2016) (4)
- Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole (2021) (4)
- Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments (2021) (4)
- Thrombospondin as a component of the extracellular matrix of epiretinal membranes: comparisons with cellular fibronectin. (1994) (4)
- Intraocular Sustained-Release Drug Delivery in Uveitis (2006) (4)
- Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials. (2020) (4)
- Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH. (2021) (4)
- Cataract extraction in the diabetic patient. (1993) (4)
- Posterior Segment Involvement in Ocular Sarcoidosis (2002) (3)
- Adalimumab in Patients with Active, Noninfectious Uveitis Using High-Dose Corticosteroids (2015) (3)
- Bilateral Retinal Detachments Presenting With Acute Angle Closure. (2018) (3)
- Ouabain-sensitive Na+-K+ ATPase pumps in cultured human retinal pigment epithelium. (1989) (3)
- Analysis of Peripapillary Atrophy in Relation to Macular Geographic Atrophy in Age-Related Macular Degeneration. (2016) (3)
- Fluocinolone Acetonide Intravitreal Implant for Uveitis Affecting the Posterior Segment of the Eye (2004) (3)
- Fluocinolone Acetonide Intravitreal Implant to Treat Posterior Uveitis: 2–year Results of a Multi–Center Clinical Trial (2005) (3)
- BASELINE CHARACTERISTICS OF VITREOMACULAR TRACTION PROGRESSING TO FULL-THICKNESS MACULAR OR LAMELLAR HOLES IN THE PHASE III TRIALS OF ENZYMATIC VITREOLYSIS. (2015) (3)
- Fluocinolone Acetonide Intravitreal Implant to Treat Posterior Segment Uveitis: 3–Year Results of a Multi–Center Clinical Trial (2006) (3)
- Resolution of Retinal Fluid on Optical Coherence Tomography in the Comparison of AMD Treatments Trials (CATT) (2015) (3)
- Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of AMD Treatments Trials (CATT) (2015) (3)
- Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis. (2019) (3)
- Safety and Drug Release Profile of Injectable Intravitreal Sustained–Release Fluocinolone Acetonide Device (2006) (3)
- A Phase 2 Study of Encapsulated CNTF-Secreting Cell Implant (NT-501) In Patients with Geographic Atrophy Associated with Dry AMD (2011) (3)
- Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) (2016) (3)
- Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. (1993) (3)
- Treatment of non-infectious uveitis that affects the posterior segment with a single intravitreal fluocinolone acetonide insert (FAi) – 3-year results.. (2019) (3)
- Luminate protects against hydroquinone–induced injury in human RPE cells (2019) (3)
- Baseline Predictors of Visual Acuity Response to Ranibizumab and Bevacizumab in the Comparison of AMD Treatment Trial (CATT) (2012) (3)
- Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema. (2021) (2)
- Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation with Disease Severity. (2022) (2)
- Impact of Baseline Quantitative OCT Features on Response to Risuteganib for the Treatment of Dry AMD-The Importance of Outer Retinal Integrity. (2022) (2)
- Drug Delivery for Proliferative Vitreoretinopathy: Prevention and Treatment (2006) (2)
- Fluocinolone Acetonide Sustained Drug Delivery System in the Treatment of Experimental Proliferative Vitreoretinopathy (2002) (2)
- MUST Beg to Differ. (2019) (2)
- Expression of CD 44 and Variant Isoforms in Cultured Human Retinal Pigment Epithelial Cells (2005) (2)
- Retinal Angiomatous Proliferation and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) (2015) (2)
- Multidisciplinary Ophthalmic Imaging Longitudinal Analysis of Reticular Drusen Associated With Geographic Atrophy in Age-Related Macular Degeneration (2013) (2)
- Combined Fluocinolone Acetonide Sustained Drug Delivery System Implantation and Phacoemulsification/Intraocular Lens Implantation in Patients with Severe Uveitis (2003) (2)
- characteristics of autoimmune retinopathy SD-OCT and autofluorescence (2013) (2)
- Fluocinolone Acetonide Formulated with Sodium Hyaluronate as a Sustained Release Drug Delivery Pellet in the Treatment of Experimental Proliferative Vitreoretinopathy (2003) (2)
- Meta-learning approach to automatically register multivendor retinal images (2020) (2)
- Size and Growth of Geographic Atrophy During 5 Years of Follow Up in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) (2016) (2)
- Comparison of RC and Investigator Determined Retinal and Subretinal fluid in the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT) (2012) (2)
- Structure-function correlation of optical coherence tomography features and visual outcome in a fixed and a PRN regimen in neovascular AMD (2014) (2)
- Lesion Characteristics and Progression in the Natural History of Geographic Atrophy (GAP)-Study (2009) (2)
- Fluocinolone Acetonide Sustained Drug Delivery Device for Chronic Retinal Venous Occlusive Disease (2006) (2)
- A Dedicated Low-Cost Fluorescence Microfluidic Device Reader for Point-of-Care Ocular Diagnostics (2013) (2)
- VALIDATION OF A DEEP LEARNING-BASED ALGORITHM FOR SEGMENTATION OF THE ELLIPSOID ZONE ON OPTICAL COHERENCE TOMOGRAPHY IMAGES OF AN USH2A-RELATED RETINAL DEGENERATION CLINICAL TRIAL (2022) (2)
- Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). (2022) (2)
- Nondegradable Intraocular Sustained-Release Drug Delivery Devices (2006) (1)
- Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration (2020) (1)
- Bacillary Layer Retinal Detachment in Neovascular Age-Related Macular Degeneration. (2022) (1)
- Choroidal Neovascularization in Familial Transthyretin Amyloidosis. (2021) (1)
- Diagnosis of Macular Edema in Patients with Uveitis (2011) (1)
- Characteristics of Patients with Good Visual Acuity at 5 Years Despite No Treatment after 2 Years in the Comparison of AMD Treatment Trials (CATT) Follow-up Study (2017) (1)
- Nitric Oxide in Ocular Inflammation (1997) (1)
- Automated, software based differentiation of diabetic macular edema from pseudophakic cystoid macular edema using SD-OCT (2015) (1)
- Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report From a US Food and Drug Administration-Cosponsored Forum. (2020) (1)
- Follow up at 5 Years of Non-Fibrotic Scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). (2018) (1)
- Complement-mediated Injury in Cultured Human RPE Cells (2011) (1)
- Chapter 79 – Intermediate Uveitis (2013) (1)
- Spontaneous Dislocation of the Pellet from the Strut in the Fluocinolone Acetonide Sustained Release Implant (Retisert (2013) (1)
- Sustained Severe Visual Acuity Loss in the Comparison of AMD Treatments Trials (CATT) (2013) (1)
- Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Authors' reply (2004) (1)
- Morphological assessment of the retina in uveitis (2016) (1)
- Risk factors for retinal scar development in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) (2017) (1)
- PPD and Positive Skin Test Controls in the Evaluation of Anergy in Uveitis Patients (2008) (1)
- The impact of macular edema on visual function in uveitis (2011) (1)
- An Injectable Fluocinolone Acetonide Intravitreal Insert Decreases the Incidence of Recurrence in Patients with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye: 12 Month Results (2017) (1)
- Prediction for Two-Year Vision Outcomes Using Early Morphological and Functional Responses in the Comparison of AMD Treatments Trials (CATT). (2023) (0)
- Pharmacologic inhibition of experimental proliferative vitreoretinopathy (PVR) using a triamcinolone/5-fluorouracil codrug sustained release pellet (1996) (0)
- Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging (2021) (0)
- In-vivo quantitative analysis of pterygium volume using anterior segment optical coherence tomography imaging (2020) (0)
- AntieVascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration Systematic Literature Review and Expert Opinion (0)
- Correlation of Retinal Morphology and Visual Acuity in the Comparison of Age-Related Macular Degeneration Treatment Trial (CATT) (2012) (0)
- Longitudinal Analysis Of The Topographic Progression Of Geographic Atrophy Secondary To Age-related Macular Degeneration (2012) (0)
- The Effect of Adenovirus-mediated Overexpression of Mutant IB on IL-1ß-induced NF-B Activation in Cultured Human RPE Cells (2002) (0)
- Deep learning-based automatic segmentation of retinal cavitations on OCT images of MacTel2 (2020) (0)
- Diagnostic Yield of Vitreous Biopsy in Sarcoid Uveitis (2007) (0)
- A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema (2015) (0)
- Incidence and risk factors for neovascular AMD in the fellow eye in the Comparison of AMD Treatment Trials (CATT) Follow-up Study (2017) (0)
- Automatic Segmentation Of Diabetic Macular Edema In Spectral Domain Optical Coherence Tomography (2012) (0)
- Outer Retinal Tubulations in the Comparison of AMD Treatments Trials (CATT) (2013) (0)
- The Protective Effect of Bax Inhibitor 1 (BI-1) on Tunicamycin-induced Human RPE Cell Death (2016) (0)
- Development of a 1.5 year ganciclovir implant for CMV retinitis (1996) (0)
- The Role of Nrf-2 in Alternative Pathway (AP) Complement and Hydroquinone (HQ)-mediated Heme Oxygenase-1 (HO-1) Expression in Human RPE (hRPE) Cells (2014) (0)
- Proteomics Analysis of Protein Expression in Human RPE Cells Exposed to Oxidant and Complement Attack through Alternative Pathway (2014) (0)
- Baseline visual fields in the RUSH2A study: Associated factors and correlation with measures of disease severity (2020) (0)
- An illuminated cannula for subretinal operations. (1993) (0)
- Survival Factor Expression and Distribution in Wild-Type Mouse Eyes (2008) (0)
- Diagnosis of Cystoid Macular Edema: Imaging (2017) (0)
- Effect of Terminal Complement Membrane Attack Complex/C5b-9 on RPE Cell Viability (2010) (0)
- Robotically aligned optical coherence tomography for socially distanced clinical ophthalmic imaging (2021) (0)
- OCT Reading Center Grader Agreement for OCT in Neovascular Age–Related Macular Degeneration (2006) (0)
- Chronic Inflammation After YAG Capsulotomy. (2018) (0)
- The Utility Of Diagnostic Testing In Uveitis Patients (2006) (0)
- Intravitreous Injection Of Antivascular Endothelial Growth Factor Combined With Injection Of Expansile Gas For Treatment Of Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion (2011) (0)
- Automatic Segmentation of Cysts in Retinal SDOCT Images using Graph Theory and Dynamic Programming (2012) (0)
- Intermediate Uveitis (2020) (0)
- Chapter 55 – Steroids in Macular Disease (2006) (0)
- Resolution of outer retinal abnormalities in eyes with vitreomacular traction without macular hole in the OASIS trial (2022) (0)
- Retina Analysis of Peripapillary Atrophy in Relation to Macular Geographic Atrophy in Age-Related Macular Degeneration (2016) (0)
- Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab. (2022) (0)
- Novel software to assess correlation between MAIA microperimetry and OCT imaging of ellipsoid zone in type 2 idiopathic macular telangiectasia (2016) (0)
- Linking optical coherence tomographic, angiographic and photographic lesion components in neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials (2017) (0)
- 0.18 mg fluocinolone acetonide insert for the treatment of chronic post-operative pseudophakic cystoid macular edema. (2023) (0)
- Clearance of antitransferrin receptor immunotoxin from the rabbit eye. (1996) (0)
- Semi-Automated Segmentation of Hyperreflective Foci on Optical Coherence Tomography (2018) (0)
- Long term Follow up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) (2018) (0)
- Expression and Distribution of Membrane Complement Regulatory Proteins in the Mouse Posterior Segment (2008) (0)
- DIAGNOSTIC AND THERAPEUTIC CHALLENGES (2002) (0)
- Retinal Thickness Measurements in Spectral Domain versus Time Domain Optical Coherence Tomography (2008) (0)
- Effect of Bax Inhibitor 1 overexpression on Tunicamycin-induced ER Stress in Human RPE Cells (2017) (0)
- Hydroquinone Sensitizes Human RPE Cells to Basal Complement Attack by the Alternative Pathway (2013) (0)
- OCT Reading Center Inter– and Intra–Grader Agreement for Diabetic Macular Edema (2005) (0)
- The Effect of Combined Oxidant Exposure and AP Complement Attack on Oxidant Production and Gene Expression in Human RPE Cells (2012) (0)
- Autonomous robotic alignment enables remote, telehealth OCT, and OCTA retinal imaging (2022) (0)
- Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment (2019) (0)
- Human RPE Cell Injury Mediated by Oxidative Stress and Alternative Complement Cascade (2012) (0)
- Response Letter to the Editor Correspondence: Correlation of Subretinal Hyperreflective Material Morphology and Visual Acuity in Neovascular Age-related Macular Degeneration. (2021) (0)
- Pre–Treatment Prognosticators of Response to a Fluocinolone Acetonide Implant for Diabetic Macular Edema (2006) (0)
- Clinical Outcomes of Eyes with Neovascular Lesions Composed of >50% Blood Treated with Anti-VEGF Therapy in the Comparison of AMD Treatments Trials (CATT) (2013) (0)
- Impact of Spectral-Domain Optical Coherence Tomography (SD-OCT)-Determined Morphology in Geographic Atrophy Due to Age-Related Macular Degeneration on Lesion Size, Rate of Progression, and the Presence of Multifocal or Unifocal Lesions (2012) (0)
- Effect of Tec Kinases Inhibitor on Complement-mediated Release of Basic Fibroblast Growth Factor from Human RPE Cells (2018) (0)
- Efficacy and pharmacokinetics of intravitreal sustained release triamcinolone/5-FU codrug suspension in the treatment of experimental PVR (1996) (0)
- Primary Vitreoretinal Lymphoma Masquerading as Post-Operative Endophthalmitis in a Pregnant Patient with Longstanding Idiopathic Panuveitis. (2023) (0)
- Screening for Patient Eligibility Using Fundus Autofluorescence in a Randomized Interventional Clinical Trial for Geographic Atrophy Secondary to Age-Related Macular Degeneration (2010) (0)
- Effect of Cytokines and Hydroquinone on Complement Regulatory Proteins in Human RPE Cells (2007) (0)
- Risuteganib Modifies Hydroquinone-regulated Gene Expression and Protects against Hydroquinone-induced Cytotoxic Effects in Human RPE Cells (2020) (0)
- Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. (2023) (0)
- Fluocinolone acetonide sustained drug-delivery implant for posterior segment eye diseases (2019) (0)
- Intravitreal implant: showing promise in DME and vein occlusion (2006) (0)
- Assessment of Retinal Pigment Epithelium (RPE) Atrophy in a Phase 2b Study of a Platelet Derived Growth Factor inhibitor (Fovista®), in combination with a Vascular Endothelial Growth Factor inhibitor (Ranibizumab) for Neovascular Age-Related Macular Degeneration (NAMD). (2016) (0)
- A New Ocular Brachytherapy System for the Treatment of Exudative AMD (2005) (0)
- The Effect of High-Fat Diet and Blue Light Exposure on the Development of Sub-RPE Deposits and RPE Injury in CD55/CD59 Double Deficient Mice (2009) (0)
- Databases have their place, but individual serial measurements are the gold standard for tracking disease. (2012) (0)
- Joint Multimodal Deep Learning-based Automatic Segmentation of Indocyanine Green Angiography and OCT Images for Assessment of Polypoidal Choroidal Vasculopathy Biomarkers. (2023) (0)
- Effect of Complement and Oxidants on Human Retinal Pigment Epithelial (RPE) Cell Survival in Age related Macular Degeneration (AMD) (2009) (0)
- Anti-transferrin receptor immunotoxin in the treatment of proliferative vitreoretinopathy (1992) (0)
- Reply. (2021) (0)
- Effect of OCT Scan Mode on the Detection of Macular Pathology in Eyes With Neovascular AMD (2007) (0)
- Role of Caspase–8 in RPE Cell Resistance to TNF––Mediated Cell Death (2006) (0)
- Predicting the Outcome of Bevacizumab in the Treatment of Neovascular AMD (2008) (0)
- 57084 Combining artificial intelligence and robotics: a novel fully automated optical coherence tomography-based approach for eye disease screening (2021) (0)
- Retina Differentiation of Diabetic Macular Edema From Pseudophakic Cystoid Macular Edema by Spectral-Domain Optical Coherence Tomography (2015) (0)
- Effects of resveratrol and hydroquinone on the endoplasmic reticulum and mitochondria in human RPE cells (2018) (0)
- Human RPE Cell Survival Factor Gene Expression in situ Compared to Expression in vitro (2005) (0)
- Uveitis Treated With Fluocinolone Acetonide Implants--Reply (2009) (0)
- Effect of Alternative Pathway Complement Activation on Cell Mortality and Survival Factor Expression in Cultured Human RPE Cells (2008) (0)
- Combined Complement Deregulation and Oxidative Stress in SOD1/CD59a null Mice Develop AMD-like Phenotypes (2016) (0)
- Short and long term exposure of intraocular lenses to silicone oil after vitrectomy and silicone oil tamponade (1997) (0)
- Pseudomonas endophthalmitis following 0.59 mg fluocinolone acetonide surgical implant in a patient with a longstanding Crawford tube (2022) (0)
- The Critical Role of Bcl-xL in Mouse Retinal Pigment Epithelial Cells (2010) (0)
- Complement-mediated release of fibroblast growth factor 2 from human RPE cells. (2021) (0)
- Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy ? Trial data may soon tell (2016) (0)
- DUKE ADVANCED VITREOUS SURGERY COURSE AND THE DUKE FELLOWS ADVANCED VITREOUS SURGERY COURSE. (2018) (0)
- Complement Membrane Attack Complex Release Basic Fibroblast Growth Factor from Human RPE Cells (2017) (0)
- Diagnostic and Therapeutic Challenges. (2018) (0)
- Associations of retinal and choroidal thickness with visual acuity at year 5 in the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT) (2017) (0)
- The Effect Of Bcl-xL On Oxidant-mediated Pro- And Anti-survival Factor Expression In Human RPE Cells (2011) (0)
- Complement Attack by the Alternative Pathway Increases Gene Expression and Protein Expression of ER Stress Markers in Human RPE Cells (2014) (0)
- Deep learning-based automatic segmentation of ellipsoid zone defects in optical coherence tomography images of macular telangiectasia type 2 (2018) (0)
- Risk Factors for Scarring in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) (2013) (0)
- Cystoid Macular Edema as a Marker in the Progression of Autoimmune Retinopathy (2017) (0)
- New Developments in Vision Research A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies : Findings and Lessons Learned (2019) (0)
- Standardized Classification of Ocular Trauma (1997) (0)
- Diagnostic and therapeutic challenges. (2013) (0)
- Pale-Centered Retinal Hemorrhages Following Vitrectomy (1987) (0)
- Baseline Predictors of Five-Year Visual Acuity in the Comparison of AMD Treatment Trials (CATT) (2017) (0)
- Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study (2018) (0)
- Longitudinal Structure/Function Correlation Between Microperimetry and OCT Imaging in Type 2 Macular Telangiectasia (MacTel) (2018) (0)
- POSTERIOR SURFACE CONDENSATION ON SILICONE IOLS. AUTHORS' REPLY (1995) (0)
- Results of Cataract Extraction and Filtration Surgery Following Fluocinolone Acetonide Sustained Drug Delivery Implant for Posterior Uveitis (2007) (0)
- Distribution of optical coherence tomographic morphologic components within areas appearing as atrophic or scarred after two years of anti-VEGF treatment for neovascular age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials (2017) (0)
- Hydrogen Peroxide– and Growth Factor–Mediated Akt Activation in Human RPE Cells (2005) (0)
- The Effect of CNTF on Retinal Thickness in Eyes With AMD Associated With Geographic Atrophy (2009) (0)
- Effect of TNF– on survival factor expression in human RPE cells (2004) (0)
- Joint multimodal deep learning-based automatic segmentation of ICGA and OCT images for assessment of PCV biomarkers (2023) (0)
- Invited Speakers and Discussants (Commercial Relationship Disclosure) (2017) (0)
- Complement-mediated Apolipoprotein E Accumulation in Cultured Human RPE Cell (2015) (0)
- Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension: by M.D. Cole, P.M. Dodson, and S. Hendeles. Br J Ophthalmol 73:693–698, 1989 (1990) (0)
- Reply. (2021) (0)
- SRF Exposure Up–Regulates Cytokine and Anti–Apoptotic Factor Expression in Cultured Human RPE Cells (2004) (0)
- Phase III studies of brolucizumab versus aflibercept in nAMD: 48-week primary and key secondary outcomes from HAWK/HARRIER (2018) (0)
- Lab-on-a-disk immunoassay for ocular diagnostics (2014) (0)
- Evaluation of Signal Strength and Spectral Domain OCT Image Artifacts (2009) (0)
- Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10 (2022) (0)
- A Progress Report on the TheraSight Ocular Brachytherapy Safety and Feasibility Study (2006) (0)
- The in vitro Efficacy of Combining Temozolomide With O6–Benzylguanine in Human Choroidal Melanoma Cell Lines (2006) (0)
- The Association of Apolipoprotein E and Membrane Attack Complex in Human RPE Cell (2016) (0)
- IL-I: A potential regulator of growth and differentiation in endometrial cancer (1991) (0)
- Resveratrol protects against hydroquinone-induced damage in RPE cells (2019) (0)
- Deep learning-based automatic segmentation of intact ellipsoid zone area on optical coherence tomography images of USH2A-related retinal degeneration (2020) (0)
- Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2 (2018) (0)
- THU0561 Adalimumab in Patients with Active and Inactive, Non-Infectious Uveitis: Visual I and Visual II Trials (2016) (0)
- Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials (2022) (0)
- Cyclosporine and neovascularization: Authors’ reply (1999) (0)
- Comparison of spectral domain and time domain OCT for qualitative and quantitative fluid assessments in the Comparison of AMD Treatments Trials (CATT) (2013) (0)
- Expression of Aquaporin-1 Protein in Human Retinal Pigment Epithelium (2002) (0)
- Recurrence rates in ocular non-infectious uveitis according to US FDA criteria or Rest of World criteria (2022) (0)
- Pale-centered retinal hemorrhages following vitrectomy. Case report. (1987) (0)
- Reticular Pseudodrusen: Inter-Reader Agreement of Evaluation on OCT Imaging in Age-Related Macular Degeneration (2023) (0)
- The Association of Subretinal Hyper-Reflective Material (SHRM) and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) (2015) (0)
- Resistance to TNF--Induced Cell Death by Overexpressing Mutant IB in Human RPE Cells (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Glenn Jay Jaffe?
Glenn Jay Jaffe is affiliated with the following schools:
